TY  - GEN
AU  - Escobar, Carlos
AU  - Pascual-Figal, Domingo A
AU  - Manzano, Luis
AU  - Nuñez, Julio
AU  - Camafort Babkowski, Miguel
PY  - 2023
DO  - 10.3390/jcm12216798
SN  - 2077-0383
UR  - http://hdl.handle.net/20.500.12105/19342
AB  - Heart failure (HF) is associated with a high morbidity and mortality burden. In light of more recent evidence, SGLT2 inhibitors are currently recommended as first-line therapy in managing patients with HF, regardless of ejection fraction, to reduce HF...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
TI  - Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin.
TY  - review article
ER  -